Target intelligence / Profile preview

RNA, U6 small nuclear 145, pseudogene (RNU6-145P)

Target: RNU6-145P
Molecular classification: Other

Overview

RNA, U6 small nuclear 145, pseudogene (RNU6-145P) is a processed pseudogene derived from the gene encoding U6 small nuclear RNA, which is a highly conserved non-coding RNA component of the spliceosome complex involved in pre-mRNA splicing[1][2][3]. Pseudogenes like RNU6-145P do not encode functional RNAs or proteins and do not have a direct biological role in splicing or any other cellular process. Instead, they reflect past retrotransposition events and may serve as genomic markers of such activity[3]. As it is a pseudogene, it is not considered a therapeutic target, nor is it involved in biological functions or disease roles.

Other names: RNU6-145P

Beyond the preview

Go deeper on RNA, U6 small nuclear 145, pseudogene (RNU6-145P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 145, pseudogene (RNU6-145P).

Explore the full profile